• news.cision.com/
  • AddLife/
  • The board of directors of AddLife AB (publ) proposes a dividend of SEK 0.50 per share

The board of directors of AddLife AB (publ) proposes a dividend of SEK 0.50 per share

Report this content

In light of the general uncertainty that prevails and the measures introduced to reduce the spread of infection of COVID-19, the board of directors of AddLife AB (publ), reg. no. 556995-8126, (“AddLife”) resolved on 6 April 2020, for precautionary reasons, to withdraw its proposed dividend of SEK 0.80 per share to the Annual General Meeting. The Annual General Meeting resolved in accordance with the board of directors’ amended proposal and no dividend was paid to the shareholders.

In recent months, uncertainty has decreased and AddLife has had high activity with very strong demand from healthcare in many of its group companies, whereby the group has strengthened its financial position and liquidity. Accordingly, the board of directors considers that AddLife has the prerequisites to proceed with a distribution of dividend.  

In the light of above, the board of directors has resolved to convene an Extraordinary General Meeting and to propose that the meeting resolves on a dividend of SEK 0.50 per share, irrespectively of class of shares, equivalent to a total of approximately SEK 56 million. As record date for receipt of dividend the board of directors proposes Monday, 23 November 2020. If the meeting resolves in accordance with the proposal, the dividend is estimated to be paid out through the agency of Euroclear Sweden on Thursday, 26 November 2020.

The complete proposal, including the terms and conditions for the distribution of dividend, will be specified in the upcoming notice to the Extraordinary General Meeting to be held on 19 November 2020.

For further information, please contact:
Kristina Willgård, CEO, AddLife AB, kristina.willgard@add.life, phone +46 (0)70 510 12 23,
Martin Almgren, CFO, AddLife AB, martin.almgren@add.life, phone +46 (0)70 228 15 45.


AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors, mainly in the Nordic region and the rest of Europe.  AddLife has about 1,000 employees in some 50 subsidiaries,. The Group currently has net sales of approximately SEK 4.5 billion. AddLife shares are listed on the NASDAQ Stockholm.

This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 20 October 2020 at 6.00 p.m CET.